review

Open Access
Early-stage CCNG1+ HR+ HER2+ Invasive Breast Carcinoma in Older Women: Current Treatment and Future Perspectives for DeltaRex-G, a CCNG1 Inhibitor
SANT P. CHAWLA, OLGA OLEVSKY, GEETA IYENGAR, DON A. BRIGHAM, NADEZHDA OMELCHENKO, SONU THOMAS, KUSHAL SURYAMOHAN, LELAND FOSHAG, FREDERICK L. HALL and ERLINDA M. GORDON

Anticancer Research June 2023, 43 (6) 2383-2391; DOI: https://doi.org/10.21873/anticanres.16406
Open Access
The Clinical Impact of the Tumor Stroma Ratio in Gastrointestinal Cancer Treatment
TORU AOYAMA, ITARU HASHIMOTO and TAKASHI OSHIMA

Anticancer Research May 2023, 43 (5) 1877-1883; DOI: https://doi.org/10.21873/anticanres.16346
Open Access
Personalized Palliative and Survivorship Care for Patients With Metastatic Cancer Treated With Radiation Therapy
SANA SIDDIQUI, LUANN ROWLAND, EMILY COPEL, ASHISH SANGAL, VIKRAM SONI, PATRICIA ECKARDT and JOHNNY KAO

Anticancer Research April 2023, 43 (4) 1387-1395; DOI: https://doi.org/10.21873/anticanres.16287
Open Access
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix
AI MIYOSHI, YUTAKA UEDA, TOMOKO KURITA, TADASHI KIMURA and KIYOSHI YOSHINO

Anticancer Research April 2023, 43 (4) 1397-1405; DOI: https://doi.org/10.21873/anticanres.16288
Open Access
Lung Cancer – Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators
JEROME H. CHECK, TRINA PORETTA, DIANE CHECK and MAYA SRIVASTAVA

Anticancer Research March 2023, 43 (3) 951-965; DOI: https://doi.org/10.21873/anticanres.16240
Open Access
Homologous Recombination Defects and Mutations in DNA Damage Response (DDR) Genes Besides BRCA1 and BRCA2 as Breast Cancer Biomarkers for PARP Inhibitors and Other DDR Targeting Therapies
IOANNIS A. VOUTSADAKIS and ATHINA STRAVODIMOU

Anticancer Research March 2023, 43 (3) 967-981; DOI: https://doi.org/10.21873/anticanres.16241
Open Access
The Potential Impact of New Drug and Therapeutic Modalities on Drug Resistance to Renal Cell Carcinoma
PEDRO CAETANO PINTO

Anticancer Research March 2023, 43 (3) 983-991; DOI: https://doi.org/10.21873/anticanres.16242
Open Access
The Latest Treatments for Cancer Cachexia: An Overview
HAYATO WATANABE and TAKASHI OSHIMA

Anticancer Research February 2023, 43 (2) 511-521; DOI: https://doi.org/10.21873/anticanres.16188
Open Access
Intramedullary Spinal Cord Metastases from Breast Cancer: A Systematic Review
GIANLUCA SCALIA, ROBERTA COSTANZO, ANNA VIOLA, LAPO BONOSI, MASSIMILIANO PORZIO, ANDREA GIOVANNINI, FRANCESCA GRAZIANO, DOMENICO GERARDO IACOPINO, ROSARIO MAUGERI, GIOVANNI FEDERICO NICOLETTI and GIUSEPPE EMMANUELE UMANA

Anticancer Research February 2023, 43 (2) 523-535; DOI: https://doi.org/10.21873/anticanres.16189
Open Access
Appraising Animal Models of Prostate Cancer for Translational Research: Future Directions
ELISABETE NASCIMENTO-GONCALVES, FERNANDA SEIXAS, RUI M. GIL DA COSTA, MARIA JOAO PIRES, MARIA JOAO NEUPARTH, DANIEL MOREIRA-GONCALVES, MARGARIDA FARDILHA, ANA I. FAUSTINO-ROCHA, BRUNO COLACO, RITA FERREIRA and PAULA A. OLIVEIRA

Anticancer Research January 2023, 43 (1) 275-281; DOI: https://doi.org/10.21873/anticanres.16160

Main menu

User menu

Search

review

Pages